These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 17143529

  • 1. Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro.
    Festuccia C, Muzi P, Gravina GL, Millimaggi D, Speca S, Dolo V, Ricevuto E, Vicentini C, Bologna M.
    Int J Oncol; 2007 Jan; 30(1):193-200. PubMed ID: 17143529
    [Abstract] [Full Text] [Related]

  • 2. In vitro and in vivo effects of bicalutamide on the expression of TrkA and P75 neurotrophin receptors in prostate carcinoma.
    Festuccia C, Gravina GL, Muzi P, Pomante R, Ventura L, Ricevuto E, Vicentini C, Bologna M.
    Prostate; 2007 Sep 01; 67(12):1255-64. PubMed ID: 17596848
    [Abstract] [Full Text] [Related]

  • 3. Mixed-lineage kinase inhibitors require the activation of Trk receptors to maintain long-term neuronal trophism and survival.
    Wang LH, Paden AJ, Johnson EM.
    J Pharmacol Exp Ther; 2005 Mar 01; 312(3):1007-19. PubMed ID: 15525794
    [Abstract] [Full Text] [Related]

  • 4. Nerve growth factor regulates substance P in adult sensory neurons through both TrkA and p75 receptors.
    Skoff AM, Adler JE.
    Exp Neurol; 2006 Feb 01; 197(2):430-6. PubMed ID: 16300761
    [Abstract] [Full Text] [Related]

  • 5. Correlations among neural cell adhesion molecule, nerve growth factor, and its receptors, TrkA, TrkB, TrkC, and p75, in perineural invasion by basal cell and cutaneous squamous cell carcinomas.
    Chen-Tsai CP, Colome-Grimmer M, Wagner RF.
    Dermatol Surg; 2004 Jul 01; 30(7):1009-16. PubMed ID: 15209791
    [Abstract] [Full Text] [Related]

  • 6. Pan-trk inhibition decreases metastasis and enhances host survival in experimental models as a result of its selective induction of apoptosis of prostate cancer cells.
    Weeraratna AT, Dalrymple SL, Lamb JC, Denmeade SR, Miknyoczki S, Dionne CA, Isaacs JT.
    Clin Cancer Res; 2001 Aug 01; 7(8):2237-45. PubMed ID: 11489797
    [Abstract] [Full Text] [Related]

  • 7. Modulation of neurotrophin and neurotrophin receptor expression in nasal mucosa after nasal allergen provocation in allergic rhinitis.
    Raap U, Fokkens W, Bruder M, Hoogsteden H, Kapp A, Braunstahl GJ.
    Allergy; 2008 Apr 01; 63(4):468-75. PubMed ID: 18266897
    [Abstract] [Full Text] [Related]

  • 8. Trk receptor inhibition induces apoptosis of proliferating but not quiescent human osteoblasts.
    Pinski J, Weeraratna A, Uzgare AR, Arnold JT, Denmeade SR, Isaacs JT.
    Cancer Res; 2002 Feb 15; 62(4):986-9. PubMed ID: 11861369
    [Abstract] [Full Text] [Related]

  • 9. Neurotrophin receptor expression in human primary retinoblastomas and retinoblastoma cell lines.
    Stephan H, Zakrzewski JL, Bölöni R, Grasemann C, Lohmann DR, Eggert A.
    Pediatr Blood Cancer; 2008 Feb 15; 50(2):218-22. PubMed ID: 17973327
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Gene expression profile of prostate cancer cell lines: effect of nerve growth factor treatment.
    Sigala S, Bodei S, Missale C, Zani D, Simeone C, Cunico SC, Spano PF.
    Mol Cell Endocrinol; 2008 Mar 12; 284(1-2):11-20. PubMed ID: 18280641
    [Abstract] [Full Text] [Related]

  • 12. Prognostic and biological role of neurotrophin-receptor TrkA and TrkB in neuroblastoma.
    Eggert A, Ikegaki N, Liu XG, Brodeur GM.
    Klin Padiatr; 2000 Mar 12; 212(4):200-5. PubMed ID: 10994551
    [Abstract] [Full Text] [Related]

  • 13. Nerve growth factor signaling in prostate health and disease.
    Arrighi N, Bodei S, Zani D, Simeone C, Cunico SC, Missale C, Spano P, Sigala S.
    Growth Factors; 2010 Jun 12; 28(3):191-201. PubMed ID: 20166899
    [Abstract] [Full Text] [Related]

  • 14. Nerve growth factor-induced protein kinase C stimulation contributes to TrkA-dependent inhibition of p75 neurotrophin receptor sphingolipid signaling.
    Plo I, Bono F, Bezombes C, Alam A, Bruno A, Laurent G.
    J Neurosci Res; 2004 Aug 15; 77(4):465-74. PubMed ID: 15264216
    [Abstract] [Full Text] [Related]

  • 15. Cotransfection of TrkA and p75(NTR) in neuroblastoma cell line (IMR-32) promotes differentiation and apoptosis of tumor cells.
    Chen J, Zhe X.
    Chin Med J (Engl); 2003 Jun 15; 116(6):906-12. PubMed ID: 12877805
    [Abstract] [Full Text] [Related]

  • 16. Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555).
    George DJ, Dionne CA, Jani J, Angeles T, Murakata C, Lamb J, Isaacs JT.
    Cancer Res; 1999 May 15; 59(10):2395-401. PubMed ID: 10344749
    [Abstract] [Full Text] [Related]

  • 17. Anti-proliferative effect of the kinase inhibitor K252a on human prostatic carcinoma cell lines.
    Delsite R, Djakiew D.
    J Androl; 1996 May 15; 17(5):481-90. PubMed ID: 8957691
    [Abstract] [Full Text] [Related]

  • 18. [Expressions of neurotrophic factors and their receptors in prostate cancer].
    Liu M, Su YH, Chen Y.
    Zhonghua Nan Ke Xue; 2010 Feb 15; 16(2):129-31. PubMed ID: 20369695
    [Abstract] [Full Text] [Related]

  • 19. Regulation of NGF responsiveness in human neuroblastoma.
    Bogenmann E, Peterson S, Maekawa K, Matsushima H.
    Oncogene; 1998 Nov 05; 17(18):2367-76. PubMed ID: 9811468
    [Abstract] [Full Text] [Related]

  • 20. Expression of nerve growth factor receptors and their prognostic value in human pancreatic cancer.
    Zhang Y, Dang C, Ma Q, Shimahara Y.
    Oncol Rep; 2005 Jul 05; 14(1):161-71. PubMed ID: 15944784
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.